Decentralized biomarker testing is pivotal for cancer screening, risk evaluation, and longitudinal surveillance, yet most established assays remain laboratory-centric that are not suitable for point-of-care testing (POCT). Saliva has attracted...
Zhang et al. (Thu,) studied this question.